Sloatsburg, NJ, United States of America

Rod L Hartwig

This inventor holds 5 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Starton Therapeutics, Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rod L Hartwig. Retrieved from https://idiyas.com/inventor/rod-l-hartwig-tse3te8o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Sloatsburg, NY (US) (2021)
  • Sloatsburg, NJ (US) (2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Rod L Hartwig

Introduction

Rod L Hartwig is a notable inventor based in Sloatsburg, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for immune-mediated inflammatory diseases and nausea. With a total of 5 patents to his name, Hartwig's work has the potential to impact many lives.

Latest Patents

One of Hartwig's latest patents is focused on stable solutions of immunomodulatory imide compounds for parenteral use. This patent provides compositions that comprise a stable solution of an immune-mediated inflammatory disease (IMID) agent, such as lenalidomide (LLD). The embodiments relate specifically to stable solutions of IMiDs for parenteral use. Additionally, methods of preparing these stable solutions and treating inflammatory disorders and cancers through parenteral use are also included. Another significant patent addresses the treatment of vomiting and nausea with a minimum dose of olanzapine. This patent encompasses compositions, devices, and methods for the transdermal administration of olanzapine, aimed at alleviating nausea and vomiting.

Career Highlights

Rod L Hartwig is currently associated with Starton Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments that address critical health issues.

Collaborations

Hartwig collaborates with esteemed colleagues, including James C Oliver and Marina Borovinskaya, who contribute to his research and development efforts.

Conclusion

Rod L Hartwig's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to improving healthcare solutions. His innovative work continues to pave the way for advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…